| Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls MB Appaiahgari, S Vrati Expert opinion on biological therapy 15 (3), 337-351, 2015 | 120 | 2015 |
| Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants MB Appaiahgari, R Glass, S Singh, S Taneja, T Rongsen-Chandola, ... Vaccine 32 (6), 651-656, 2014 | 89 | 2014 |
| Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis S Bhowmick, R Duseja, S Das, MB Appaiahgiri, S Vrati, A Basu Neuroscience letters 414 (1), 45-50, 2007 | 89 | 2007 |
| IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine MB Appaiahgari, S Vrati Expert review of vaccines 9 (12), 1371-1384, 2010 | 87 | 2010 |
| A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial N Bhandari, P Sharma, S Taneja, T Kumar, T Rongsen-Chandola, ... Journal of Infectious Diseases 200 (3), 421-429, 2009 | 78 | 2009 |
| Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal … MB Appaiahgari, M Saini, M Rauthan, S Vrati Microbes and infection 8 (1), 92-104, 2006 | 65 | 2006 |
| DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain MB Appaiahgari, S Vrati Molecular Therapy 15 (9), 1593-1599, 2007 | 61 | 2007 |
| Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV) MB Appaiahgari, S Vrati Expert opinion on biological therapy 12 (9), 1251-1263, 2012 | 44 | 2012 |
| Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, India L Kabilan, S Vrati, S Ramesh, S Srinivasan, MB Appaiahgari, ... Journal of clinical virology 31 (2), 153-159, 2004 | 44 | 2004 |
| Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells MB Appaiahgari, S Vrati Vaccine 22 (27-28), 3669-3675, 2004 | 44 | 2004 |
| Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines MB Appaiahgari, RM Pandey, S Vrati Clinical and Vaccine Immunology 14 (8), 1053-1055, 2007 | 40 | 2007 |
| Effect of cytokine‐encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice K Bharati, MB Appaiahgari, S Vrati Microbiology and immunology 49 (4), 349-353, 2005 | 28 | 2005 |
| Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies M Rauthan, R Kaur, MB Appaiahgari, S Vrati Microbes and infection 6 (14), 1305-1311, 2004 | 22 | 2004 |
| Expression of Japanese encephalitis virus envelope protein in transgenic tobacco plants MB Appaiahgari, MZ Abdin, KC Bansal, S Vrati Journal of virological methods 162 (1-2), 22-29, 2009 | 17 | 2009 |
| Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies R Kulandaisamy, T Kushwaha, A Dalal, V Kumar, D Singh, K Baswal, ... Frontiers in Microbiology 13, 877813, 2022 | 16 | 2022 |
| Descriptive epidemiology of rotavirus infection in a community in North India TR Chandola, S Taneja, N Goyal, SS Rathore, MB Appaiahgari, A Mishra, ... Epidemiology & Infection 141 (10), 2094-2100, 2013 | 14 | 2013 |
| Molecular cloning and characterization of chikungunya virus genes from Indian isolate of 2006 outbreak S Gupta, S Vrati J Pharm Res 55, 3860-3863, 2012 | 11 | 2012 |
| Plant-based edible vaccines: issues and advantages MB Appaiahgari, U Kiran, A Ali, S Vrati, MZ Abdin Plant biotechnology: principles and applications, 329-366, 2017 | 6 | 2017 |
| Identification of a novel inhibitor of SARS‐CoV‐2 main protease: an in silico, biochemical, and cell‐based approach A Trivedi, V Kardam, KK Inampudi, S Vrati, D Gupta, A Singh, ... The FEBS Journal 290 (23), 5496-5513, 2023 | 4 | 2023 |
| Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP7 D Singh, T Kushwaha, R Kulandaisamy, V Kumar, K Baswal, SH Tiwari, ... Molecular Therapy Nucleic Acids, 2025 | | 2025 |